Gibtulio 25mg Tablets, Strength : 25mg

Name: Gibtulio 25mg Tablets, Strength : 25mg
SKU: NEXKEM004
Rating: 2 (198 reviews)

★ 2 198 reviews Ready stock

Category: Antidiabetic Drugs

Pricing Get Latest Price 10 Strip minimum order

◉ Order / Ask on WhatsApp

Sold by Nexkem Biotech Private Limited Baddi, Himachal Pradesh, India ✓ Verified Supplier

2.2/5 ★★☆☆☆ 573 Ratings 5 active listings

PRODUCT FEEDBACK

Ratings & reviews

198 ratings

2.0★out of 5

Buyer rating★★☆☆☆Based on verified marketplace rating data

Seller experience2.2/5573 supplier ratings

Secure TransactionSafe & secure enquiry

Fast & ReliableDirect supplier response

Quality AssuredVerified seller profile

Dedicated SupportHelp when you need it

Secure payment optionsAvailable on eligible direct orders

UPI GPay PhonePe VISA ●●Cards ▣Net Banking

Secure checkout on eligible products

PRODUCT DETAILS

Everything you need before you source

Review overview, specifications and supplier information in one clear product workspace.

Buyer-ready information

PRODUCT OVERVIEW

Gibtulio 25mg Tablets, Strength : 25mg

Gibtulio 25mg tablets contain the active ingredient **bempedoic acid**, which is used to lower cholesterol levels in the blood. It is typically prescribed for patients with high cholesterol who cannot tolerate statins or need additional lowering of cholesterol despite statin use. Bempedoic acid works by inhibiting an enzyme in the liver that is crucial for cholesterol production. This helps reduce the overall cholesterol level and can lower the risk of cardiovascular events. The usual dose is one 25mg tablet taken orally once daily. Common side effects include muscle pain, abdominal pain, and nausea. It’s important to follow your healthcare provider's instructions and have regular check-ups to monitor your progress.

Direct supplier enquiryYour requirement goes straight to the listed supplier.

Commercial clarityConfirm quantity, specification, lead time and delivery before ordering.

Buyer-ready sourcingNo payment is required to request the latest quotation.